Pernix Therapeutics, Inc. logo
Pernix Therapeutics Inc. to Present at Morgan Stanley Global Healthcare Conference
September 09, 2015 07:00 ET | Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Sept. 9, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...
Pernix Therapeutics, Inc. logo
Pernix Therapeutics Announces New Revolving Credit Facility
August 24, 2015 10:46 ET | Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., Aug. 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) ("Pernix" or "the Company"), a specialty pharmaceutical company, today announced the completion of a...
Pernix Therapeutics, Inc. logo
Pernix Therapeutics Reports Second Quarter 2015 Financial Results
August 06, 2015 06:50 ET | Pernix Therapeutics Holdings, Inc.
Revenues Increase Over 150% Year-Over-Year Company Provides Updated Financial Guidance MORRISTOWN, N.J., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX)...
Pernix Therapeutics, Inc. logo
Pernix Releases Positive in vitro Abuse Deterrent Data for Third Generation Extended Release Hydrocodone ZX007
July 27, 2015 08:00 ET | Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., July 27, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX),  a specialty pharmaceutical company, today announced positive results from Category 1 (in...
Pernix Therapeutics, Inc. logo
Pernix Therapeutics Inc. to Report Second Quarter 2015 Financial Results on Thursday, August 6, 2015
July 24, 2015 11:30 ET | Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., July 24, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it will release its 2015 second quarter...
Pernix Therapeutics, Inc. logo
Pernix Therapeutics Inc. to Present at JMP Securities Life Sciences Conference
June 15, 2015 17:30 ET | Pernix Therapeutics Holdings, Inc.
MORRISTOWN, N.J., June 15, 2015 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (Nasdaq:PTX), a specialty pharmaceutical company, announced today that Doug Drysdale, Chairman, President and...